Jakob Benedict Seidelin (Jakob Seidelin, Jakob B Seidelin)

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 28

Top Topics

Ulcerative Colitis

Top Venues

Journal of Crohn's & colitis

BMJ open gastroenterology

Alimentary pharmacology & therapeutics

Crohn's & colitis 360

This page only lists publications with an associated author ORCID identifier.

Publications

Johan F K F Ilvemark, Rune Wilkens, Peter Thielsen, Anders Dige, Trine Boysen, Jørn Brynskov, Jacob T Bjerrum, Jakob Benedict Seidelin
Early intestinal ultrasound in severe ulcerative colitis identifies patients at increased risk of 1-year treatment failure and colectomy. Journal of Crohn's & colitis (2024)
Mohamed Attauabi, Casper Steenholdt, Anja Poulsen, John Mark Gubatan, Burisch J, Ole Haagen Nielsen, Jakob Benedict Seidelin
Network meta-analysis: Comparative onset of early effect of biologics and small molecules in moderately to severely active luminal Crohn's disease. Alimentary pharmacology & therapeutics 60 (2) (2024)
Pernille D Ovesen, Johan Fredrik Kristoffer Fremberg Ilvemark, Rune Wilkens, Casper Steenholdt, Jakob Benedict Seidelin
Predicting treatment response in ASUC: do we measure systemic severity, organ response or both? Gut (2024)
Mohamed Attauabi, Casper Steenholdt, Anja Poulsen, John Mark Gubatan, Burisch J, Ole Haagen Nielsen, Jakob Benedict Seidelin
Network meta-analysis: Comparative onset of early effect of biologics and small molecules in moderately to severely active luminal Crohn's disease. Alimentary pharmacology & therapeutics (2024)
Michelle V Prosberg, Sofie I Halkjær, Bobby Lo, Christina Bremerskov-Köser, Johan F K F Ilvemark, Jakob Benedict Seidelin, Malene F Kristiansen, Anja Kort, Thomas Kallemose, Peter Bager, Flemming Bendtsen, Inge Nordgaard-Lassen, Hanne S Kapel, Helene Kringel, Christian M O Kapel, Andreas M Petersen
Probiotic Treatment of Ulcerative Colitis with Trichuris suis ova: A Randomized, Double-blinded, Placebo-controlled Clinical Trial (the PROCTO Trial). Journal of Crohn's & colitis (2024)
Pernille Dige Ovesen, Mohamed Attauabi, Johan F K F Ilvemark, Mads Damsgaard Wewer, David J Warren, Johan Burisch, Rolf A Klaasen, Nils Bolstad, Casper Steenholdt, Jakob Benedict Seidelin
Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort. BMJ open gastroenterology 11 (1) (2024)
Mohamed Attauabi, Burisch J, Ole Haagen Nielsen, Jakob Benedict Seidelin
In Severe Inflammatory Bowel Disease, the Onset of Effectiveness of Biologics and Small Molecules Depends More on the Medication Than on the Diagnosis. Inflammatory bowel diseases (2024)
Jakob Benedict Seidelin, Mariana Bronze, Anja Poulsen, Mohamed Attauabi, Anders Woetmann, Benjamin E Mead, Jeffrey M Karp, Lene B Riis, Jacob T Bjerrum
Non-TGFβ profibrotic signaling in ulcerative colitis after in vivo experimental intestinal injury in humans. American journal of physiology. Gastrointestinal and liver physiology 327 (1) (2024)
Jakob Benedict Seidelin
Editorial: Time to address quality of life in our IBD treatment-IBD nurse intervention as a key part of multimodal IBD management. Alimentary pharmacology & therapeutics 59 (9) (2024)
Nora Vladimirova, Lene Terslev, Mohamed Attauabi, Gorm Roager Madsen, Viktoria Fana, Charlotte Wiell, Uffe Møller Døhn, Flemming Bendtsen, Jakob Benedict Seidelin, Burisch J, Mikkel Østergaard
Peripheral Joint and Enthesis Involvement in Patients With Newly Diagnosed Inflammatory Bowel Disease: Symptoms, and Clinical and Ultrasound Findings - A Population-Based Cohort Study. Journal of Crohn's & colitis 18 (7) (2024)
Pernille Dige Ovesen, Mohamed Attauabi, Johan F K F Ilvemark, Mads Damsgaard Wewer, David J Warren, Johan Burisch, Rolf A Klaasen, Nils Bolstad, Casper Steenholdt, Jakob Benedict Seidelin
Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort. BMJ open gastroenterology 11 (1) (2024)
Pernille Dige Ovesen, Mohamed Attauabi, Johan F K F Ilvemark, Mads Damsgaard Wewer, David J Warren, Johan Burisch, Rolf A Klaasen, Nils Bolstad, Casper Steenholdt, Jakob Benedict Seidelin
Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort. BMJ open gastroenterology 11 (1) (2024)
Anja Poulsen, Julie Rasmussen, Mads Damsgaard Wewer, Esben Holm Hansen, Rie Louise Møller Nordestgaard, Hans Søe Riis Jespersen, Dagmar Christiansen, Elena Surnacheva, Viviane Annabelle Lin, Nurcan Aydemir, Kari Anne Verlo, Frederik Rønne Pachler, Pernille Dige Ovesen, Kristian Asp Fuglsang, Christopher Filtenborg Brandt, Lars Tue Sørensen, Peter-Martin Krarup, Ismail Gögenür, Burisch J, Jakob Benedict Seidelin
Re-resection Rates and Disease Recurrence in Crohn's Disease - A Population-Based Study Using Individual-Level Patient Data. Journal of Crohn's & colitis (2024)
Mohamed Attauabi, Casper Steenholdt, Anja Poulsen, John Mark Gubatan, Burisch J, Ole Haagen Nielsen, Jakob Benedict Seidelin
Network meta-analysis: Comparative onset of early effect of biologics and small molecules in moderately to severely active luminal Crohn's disease. Alimentary pharmacology & therapeutics 60 (2) (2024)
Anja Poulsen, Pernille Dige Ovesen, Cathy Lu, Dominik Bettenworth, Vipul Jairath, Brian G Feagan, Jakob Benedict Seidelin, Florian Rieder
Serum Extracellular Matrix Molecules and Their Fragments as Biomarkers of Inflammation and Fibrosis in Inflammatory Bowel Diseases - A Systematic Review. Journal of Crohn's & colitis (2024)
Nora Vladimirova, Lene Terslev, Mohamed Attauabi, Gorm Roager Madsen, Viktoria Fana, Charlotte Wiell, Uffe Møller Døhn, Flemming Bendtsen, Jakob Benedict Seidelin, Burisch J, Mikkel Østergaard
Peripheral joint and enthesis involvement in patients with newly diagnosed inflammatory bowel disease: symptoms, clinical and ultrasound findings - a population-based cohort study. Journal of Crohn's & colitis (2024)
Jakob Benedict Seidelin
Editorial: Time to address quality of life in our IBD treatment-IBD nurse intervention as a key part of multimodal IBD management. Alimentary pharmacology & therapeutics 59 (9) (2024)
Sigrun Grimsdottir, Mohamed Attauabi, Emilie Kristine Dahl, Burisch J, Jakob Benedict Seidelin
Systematic review with meta-analysis: The impact of cancer treatments on the disease activity of inflammatory bowel diseases. Journal of Crohn's & colitis (2023)
Rikke Boedker Holmstroem, Emilie Kristine Dahl, Morten Helms, Henrik Vedel Nielsen, Janne Bayer Andersen, Jacob Tveiten Bjerrum, Inge Marie Svane, Eva Ellebaek, Jakob Benedict Seidelin
Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report. BMJ open gastroenterology 9 (1) (2023)
Mohamed Attauabi, Ditlev Nytoft Rasmussen, Fredrik Olof Bergenheim, Burisch J, Jakob Benedict Seidelin
Unraveling the Place of Small Molecules in the Treatment of Fistulizing Crohn's Disease-A Systematic Review and Network Meta-Analysis. Crohn's & colitis 360 5 (4) (2023)
Casper Steenholdt, Pernille Dige Ovesen, Jørn Brynskov, Jakob Benedict Seidelin
Tofacitinib for acute severe ulcerative colitis: a systematic review. Journal of Crohn's & colitis (2023)
Rikke Boedker Holmstroem, Emilie Kristine Dahl, Morten Helms, Henrik Vedel Nielsen, Janne Bayer Andersen, Jacob Tveiten Bjerrum, Inge Marie Svane, Eva Ellebaek, Jakob Benedict Seidelin
Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report. BMJ open gastroenterology 9 (1) (2023)
Mohamed Attauabi, Ditlev Nytoft Rasmussen, Fredrik Olof Bergenheim, Burisch J, Jakob Benedict Seidelin
Unraveling the Place of Small Molecules in the Treatment of Fistulizing Crohn's Disease-A Systematic Review and Network Meta-Analysis. Crohn's & colitis 360 5 (4) (2023)
Rikke Boedker Holmstroem, Emilie Kristine Dahl, Morten Helms, Henrik Vedel Nielsen, Janne Bayer Andersen, Jacob Tveiten Bjerrum, Inge Marie Svane, Eva Ellebaek, Jakob Benedict Seidelin
Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report. BMJ open gastroenterology 9 (1) (2023)
Jakob Benedict Seidelin, Simone Jensen, Morten Hansen, Mariana Rodrigues de Carvalho Bronze, Delphine Cuchet-Lourenҫo, Sergey Nejentsev, Eric Charles LaCasse, Ole Haagen Nielsen
IAPs and RIPK1 mediate LPS-induced cytokine production in healthy subjects and Crohn's disease. Clinical and experimental immunology (2023)
Mohamed Attauabi, Mads Damsgaard Wewer, Flemming Bendtsen, Jakob Benedict Seidelin, Burisch J
Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis. Inflammatory bowel diseases 28 (11) (2022)
Mohamed Attauabi, Camilla Höglund, Janne Fassov, Kenneth Bo Pedersen, Heidi Bansholm Hansen, Signe Wildt, Michael Dam Jensen, Anders Neumann, Cecilie Lind, Henrik Albaek Jacobsen, Ana-Maria Popa, Jens Kjeldsen, Natalia Pedersen, Akbar Molazahi, Kent Haderslev, Claus Aalykke, Torben Knudsen, Wojciech Cebula, Pia Munkholm, Flemming Bendtsen, Jakob Benedict Seidelin, Burisch J
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases. Scandinavian journal of gastroenterology 56 (9) (2021)
Simone Jensen, Jakob Benedict Seidelin, Eric Charles LaCasse, Ole Haagen Nielsen
SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases. Science signaling 13 (619) (2020)